Glycogen - PDFSEARCH.IO - Document Search Engine

Glycogen
Results: 481

#	Item
411	EQUINE EMBRYO PGD VGL Veterinary Genetics Laboratory Add to Reading List Source URL: www.vgl.ucdavis.edu Language: English - Date: 2012-10-26 12:31:50 Medicine Biology Hereditary equine regional dermal asthenia Preimplantation genetic diagnosis Credit card Glycogen-branching enzyme deficiency Hyperkalemic periodic paralysis Tobiano MasterCard American Quarter Horses Horse coat colors Health
412	October 11, 2012 Amicus Therapeutics Announces Positive Pompe Program Updates AT2220-Enzyme Replacement Therapy (ERT) Co-Administration Increases Pompe Enzyme (rhGAA) Activity in First 3 Dose Cohorts in Phase 2 Study AT Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2012-11-15 18:10:29 Lysosomal storage diseases Glycogen storage disease type II Hepatology Alglucosidase alfa Enzyme replacement therapy ERT Amyotrophic lateral sclerosis Immunogenicity Medicine Health Rare diseases
413	Expensive drug gives hope to rare disease sufferer Family wonders who will pay bill Trevor Pare, 16, suffers from a rare form of muscular dystrophy. He and his mother, Linda, worry his condition will worsen if the provin Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2007-03-14 17:43:04 Pharmacology Glycogen storage disease type II Hepatology Alglucosidase alfa Genzyme Clinical trial Muscular dystrophy Pharmaceutical industry Drug Health Medicine Pharmaceutical sciences
414	MYOZYME® (2000 L) SUPPLY UPDATE – US VERSION – JANUARY 2009 We would like to take this opportunity to provide an important update to the Pompe Community. Background In the early stages of development of Myozyme® (a Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2009-01-14 20:25:55 Hepatology Orphan drugs Alglucosidase alfa Genzyme Medicine Health Glycogen storage disease type II
415	Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease CRANBURY, N.J., October 23, [removed]Amicus Therapeutics, a biopharmaceutical company developing small molecule, Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2007-10-23 11:26:48 Science Clinical research Design of experiments Glycogen storage disease type II Hepatology Clinical trial Molecular chaperone therapy Health Medicine Lysosomal storage diseases
416	Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease CRANBURY, N.J., June 3, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2008-06-03 09:27:22 Lysosomal storage diseases Glycogen storage disease type II Hepatology Motor neurone disease Acid alpha-glucosidase Amyotrophic lateral sclerosis Clinical trial Molecular chaperone therapy Health Rare diseases Medicine
417	March 19, 2012 Community Update for Pompe Families in the United States who Utilize Myozyme® (alglucosidase alfa) Produced at the 160 L Manufacturing Scale We are writing to provide an update to those families who are c Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2012-03-19 20:39:14 Clinical research Epidemiology Genzyme Clinical trial Glycogen storage disease type II William Canfield Medicine Health Alglucosidase alfa
418	Pompe Community Update News from Patient Advocacy Summer 2011 Pompe Phase 2 Co-administration Study: AT2220-010 Amicus Therapeutics’ Pompe Program is proceeding with a Phase 2 co-administration study of AT2220, the inv Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2011-08-10 11:05:44 Clinical research Lipid storage disorders Lysosomal storage diseases Pharmaceutical industry Glycogen storage disease type II Enzyme replacement therapy Fabry disease Alglucosidase alfa Clinical trial Health Medicine Rare diseases
419	Microsoft Word - Broad PR FINAL Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2013-11-20 18:57:12 Lipid storage disorders Lysosomal storage diseases Glycogen storage disease type II Fabry disease Enzyme replacement therapy Amicus Mucopolysaccharidosis Biologic ERT Health Rare diseases Medicine
420	Winter[removed]Pompe InCommon Strong Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2010-12-08 13:10:17 Glycogen storage disease type II Hepatology Patient advocacy Caregiver Individuals with Disabilities Education Act Health Medicine Rare diseases

UPDATE